Whittemore Tingley - 29 Jul 2021 Form 3 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Chief Medical Officer
Signature
/s/ Leone Patterson Attorney-in-Fact for Whittemore Tingley
Issuer symbol
TNYA
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 19:40:29 UTC
Next filing
17 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNYA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 75,000 $0.7800 Direct F1
holding TNYA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 25,000 $5.64 Direct F2
holding TNYA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 108,333 $9.36 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option granted on December 10, 2018 became vested and exercisable as of December 7, 2018 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.
F2 1/48th of the shares subject to the option granted on January 19, 2021 became vested and exercisable as of January 19, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.
F3 1/48th of the shares subject to the option granted on June 17,2021 became vested and exercisable as of July 17, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.

Remarks:

Date set forth above represents the effective date of the Issuer's initial public offering.